These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29672831)

  • 1. Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Kovalchuk MO; Heuberger JAAC; Sleutjes BTHM; Ziagkos D; van den Berg LH; Ferguson TA; Franssen H; Groeneveld GJ
    Clin Pharmacol Ther; 2018 Dec; 104(6):1136-1145. PubMed ID: 29672831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.
    Sommer M; Tergau F; Wischer S; Reimers CD; Beuche W; Paulus W
    J Neurol; 1999 Nov; 246 Suppl 3():III22-6. PubMed ID: 10631657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
    Wainger BJ; Macklin EA; Vucic S; McIlduff CE; Paganoni S; Maragakis NJ; Bedlack R; Goyal NA; Rutkove SB; Lange DJ; Rivner MH; Goutman SA; Ladha SS; Mauricio EA; Baloh RH; Simmons Z; Pothier L; Kassis SB; La T; Hall M; Evora A; Klements D; Hurtado A; Pereira JD; Koh J; Celnik PA; Chaudhry V; Gable K; Juel VC; Phielipp N; Marei A; Rosenquist P; Meehan S; Oskarsson B; Lewis RA; Kaur D; Kiskinis E; Woolf CJ; Eggan K; Weiss MD; Berry JD; David WS; Davila-Perez P; Camprodon JA; Pascual-Leone A; Kiernan MC; Shefner JM; Atassi N; Cudkowicz ME
    JAMA Neurol; 2021 Feb; 78(2):186-196. PubMed ID: 33226425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers.
    Le Liboux A; Cachia JP; Kirkesseli S; Gautier JY; Guimart C; Montay G; Peeters PA; Groen E; Jonkman JH; Wemer J
    J Clin Pharmacol; 1999 May; 39(5):480-6. PubMed ID: 10234595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis.
    Bensimon G; Lacomblez L; Delumeau JC; Bejuit R; Truffinet P; Meininger V;
    J Neurol; 2002 May; 249(5):609-15. PubMed ID: 12021952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y; Shibuya K; Vucic S; Kiernan MC
    Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.
    Shibuya K; Misawa S; Kimura H; Noto Y; Sato Y; Sekiguchi Y; Iwai Y; Mitsuma S; Beppu M; Watanabe K; Fujimaki Y; Tsuji Y; Shimizu T; Mizuno T; Nakagawa M; Sawaguchi K; Hanaoka H; Kuwabara S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):353-8. PubMed ID: 25960085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.
    Geevasinga N; Menon P; Ng K; Van Den Bos M; Byth K; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):580-588. PubMed ID: 27249331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Meininger V
    Lancet; 1996 May; 347(9013):1425-31. PubMed ID: 8676624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole has no acute effect on motor unit parameters in ALS.
    Desai J; Sharief M; Swash M
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S69-72. PubMed ID: 9851653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
    Bensimon G; Lacomblez L; Meininger V
    N Engl J Med; 1994 Mar; 330(9):585-91. PubMed ID: 8302340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    Aggarwal SP; Zinman L; Simpson E; McKinley J; Jackson KE; Pinto H; Kaufman P; Conwit RA; Schoenfeld D; Shefner J; Cudkowicz M;
    Lancet Neurol; 2010 May; 9(5):481-8. PubMed ID: 20363190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.